Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 1, 2004, Pages 185-192

  Suzuki, H ^a,d   Nomura, S ^a,b   Masaoka, T ^a   Goshima, H ^c   Kamata, N ^b   Kodama, Y ^c   Ishii, H ^a   Kitajima, M ^a   Nomoto, K ^a   Hibi, T ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ortho Corporation Ltd

^c GHEN Corporation   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN Y ANTIBODY; LANSOPRAZOLE; PEPSINOGEN; UNCLASSIFIED DRUG; UREASE;

ADULT; ANIMAL EXPERIMENT; CASE REPORT; CONFERENCE PAPER; DRUG EFFECT; EGG YOLK; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; UREA BREATH TEST;

EID: 4344604445     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02027.x     Document Type: Conference Paper

References (42)

1. Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori induced inflammation. Gastroenterology 1992; 102: 720-7.
2. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
3. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
4. Gibaldi M. Helicobacter pylori and gastrointestinal disease. J Clin Pharmacol 1995; 35: 647-54.
5. Deloney CR, Schiller NL. Characterization of an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori. Antimicrob Agents Chemother 2000; 44: 3368-73.
6. Peitz U, Menegatti M, Vaira D, Malfertheiner P. The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut 1998; 43 (Suppl.): S66-S69.
7. Carlander D, Kollberg H, Wejaker PE, Larsson A. Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections. Immunol Res 2000; 21: 1-6.
8. Sarker SA, Casswall TH, Juneja LR, et al. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J Pediatr Gastroenterol Nutr 2001; 32: 19-25.
9. Hatta H, Tsuda K, Akachi S, Kim M, Yamamoto T, Ebina T. Oral passive immunization effect of anti-human rotavirus IgY and its behavior against proteolytic enzymes. Biosci Biotechnol Biochem 1993; 57: 1077-81.
10. Marquardt RR, Jin LZ, Kim JW, Fang L, Frohlich AA, Baidoo SK. Passive protective effect of egg-yolk antibodies against enterotoxigenic Escherichia coli K88+ infection in neonatal and early-weaned piglets. FEMS Immunol Med Microbiol 1999; 23: 283-8.
11. Sunwoo HH, Nakano T, Dixon WT, Sim JS. Immune responses in chickens against lipopolysaccharide of Escherichia coli and Salmonella typhimurium. Poult Sci 1996; 75: 342-5.
12. Ebina T. Prophylaxis of rotavirus gastroenteritis using immunoglobulin. Arch Virol 1996; 12 (Suppl.): 217-23.
13. Kuroki M, Ohta M, Ikemori Y, et al. Field evaluation of chicken egg yolk immunoglobulins specific for bovine rotavirus in neonatal calves. Arch Virol 1997; 142: 843-51.
14. Shin JH, Yang M, Nam SW, et al. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin Diagn Lab Immunol 2002; 9: 1061-6.
15. Shin JH, Nam SW, Kim JT, Yoon JB, Bang WG, Roe IH. Identification of immunodominant Helicobacter pylori proteins with reactivity to H.pylori-specific egg-yolk immunoglobulin. J Med Microbiol 2003; 52: 217-22.
16. Yamaguchi H, Osaki T, Kai M, Taguchi H, Kamiya S. Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori. Infect Immun 1992; 68: 3448-54.
17. Icatlo FCJ, Kuroki M, Kobayashi C, et al. Affinity purification of Helicobacter pylori urease. Relevance to gastric mucin adherence by urease protein. J Biol Chem 1998; 273: 18130-8.
18. Suzuki H, Masaoka T, Miyazawa M, Suzuki M, Miura S, Ishii H. Gastric mucosal response to Helicobacter pylori. Keio J Med 2002; 51(Suppl. 2): 40-4.
19. Icatlo FC, Goshima H, Kimura N, Kodama Y. Acid-dependent adherence of Helicobacter pylori urease to diverse polysaccharides. Gastroenterology 2000; 119: 358-67.
20. Kabir AMA, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997; 41: 49-55.
21. Nagata K, Mizuta T, Tonokatu Y, et al. Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations. Infect Immun 1992; 60: 4826-31.
22. Suzuki H, Miyazawa M, Nagahashi S, et al. Attenuated apoptosis in H.pylori-colonized gastric mucosa of Mongolian gerbils in comparison with mice. Dig Dis Sci 2002; 47: 90-9.
23. 13C-urea breath test with infra-red spectrophotometer. J Gastroenterol Supplement 1996; 9: 37-40.
24. Shin JH, Nam SW, Kim JT, Yoon JB, Bang WG, Roe IH. Identification of immunodominant Helicobacter pylori proteins with reactivity to H. pylori-speciftc egg-yolk immunoglobulin. J Med Microbiol 2003; 52: 217-22.
25. Xia HX, Talley NJ, Keane CT, O'Morain CA. Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci 1997; 42: 1821-34.
26. Trust TJ, Alm RA, Pappo J. Helicobacter pylori. today's treatment, and possible future treatment. Eur J Surg 2001; 586(Suppl.): 82-8.
27. Hatta H, Tsuda K, Akachi S, Kim M, Yamamoto T. Productivity and some properties of egg yolk antibody (IgY) against human rotavirus compared with rabbit IgG. Biosci Biotechnol Biochem 1993; 57: 450-4.
28. Li X, Nakano T, Sunwoo HH, Paek BH, Chae HS, Sim JS. Effects of egg and yolk weights on yolk antibody (IgY) production in laying chickens. Poult Sci 1998; 77: 266-70.
29. Verdolva A, Basile G, Fassina G. Affinity purification of immunoglobulins from chicken egg yolk using a new synthetic ligand. J Chromatogr 2000; B 749: 233-42.
30. Sugita-Konishi Y, Shibata K, Yun SS, Hara-Kudo Y, Yamaguchi K, Kumagai S. Immune functions of immunoglobulin Y isolated from egg yolk of hens immunized with various infectious bacteria. Biosci Biotechnol Biochem 1996; 60: 886-8.
31. Hatta H, Tsuda K, Ozeki M, et al. Passive immunization against dental plaque formation in humans effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Res 1997; 31: 268-74.
32. Dubois A, Lee CK, Fiala N, Kleanthous H, Mehlman PT, Monath T. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun 1998; 66: 4340-6.
33. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995; 92: 6499-503.
34. Koesling J, Lucas B, Develioglou L, Aebischer T, Meyer TF, Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy. Vaccine 2001; 12: 413-20.
35. Michetti P, Corthesy-Theulaz I, Davin C. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994; 107: 1002-11.
36. Keller WC, Michetti P. Vaccination against Helicobacter pylorian old comparison of man. Expert Opin Biol Ther 2001; 1: 795-802.
37. Phadnis SH, Parlow MH, Levy M, et al. Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect Immun 1996; 64: 905-12.
38. Marcus EA, Scott DR. Cell lysis is responsible for the appearance of extracellular urease in Helicobacter pylori. Helicobacter 2001; 6: 93-9.
39. Lee KA, Chang SK, Lee YJ, Lee JH, Koo NS. Acid stability of anti-Helicobacter pylori IgY in aqueous polyol solution. J Biochem Mol Biol 2002; 35: 488-93.
40. Nagata K, Satoh H, Iwahi T, Shimoyama T, Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob Agents Chemother 1993; 37: 769-74.
41. Matsukawa Y, Nishinarita S, Kaneko M, et al. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II. Int J Clin Pharmacol Res 1997; 17: 127-132.
42. Bodger K, Wyatt JI, Heatley RV. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy. Helicobacter 2001; 6: 216-24.